Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Raymund Razonable and Robert Orenstein.
Raymund Razonable
Connection Strength
0.590
Robert Orenstein
  1. Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19. J Clin Invest. 2021 10 01; 131(19).
    View in: PubMed
    Score: 0.243
  2. A Framework for Outpatient Infusion of Antispike Monoclonal Antibodies to High-Risk Patients with Mild-to-Moderate Coronavirus Disease-19: The Mayo Clinic Model. Mayo Clin Proc. 2021 05; 96(5):1250-1261.
    View in: PubMed
    Score: 0.233
  3. Outcomes of COVID-19 With the Mayo Clinic Model of Care and Research. Mayo Clin Proc. 2021 03; 96(3):601-618.
    View in: PubMed
    Score: 0.058
  4. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 11; 95(11):2382-2394.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.